Nuo Therapeutics, Inc. (AURX)

Operating Income Growth

33.46%

TTM · Period ending:

AURX logo

AURX Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported33.46%
AURX TTM Operating Income YoY % (82.64% → 33.46%)
High-resolution chart · PNG

AURX operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Nuo Therapeutics, Inc. Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
33.4621%
11.0584%
-2.3928%
-3.4599%
3.3087%
17.4892%
22.423%
28.7014%
25.2325%
17.2868%
4.5876%
-43.2378%
-136.338%
-502.203%
-3,562.2852%
-608.9003%
-345.3967%
-131.7346%
69.2444%
5.7662%
69.5823%
58.9358%
35.5888%
91.3404%
88.7514%
88.3515%
88.8167%
-48.4487%
-51.8393%
-65.4882%
-72.3903%
42.8885%
80.3307%
81.1741%
81.1108%
69.4561%
-123.9871%
-80.5518%
-76.6478%
-73.2635%
26.9695%
-24.6278%
-29.2666%
-27.3703%
-30.9349%
-16.8891%
-40.3292%
-97.9881%
-198.4145%
-219.4788%
-266.9196%
-72.3322%
-6.5138%
18.4367%
34.9553%
-4.7688%
-28.5215%
-61.244%
-56.6309%
29.3446%
42.2977%
53.8317%
56.303%
-63.9355%
-22.9108%
-43.565%
-45.5975%
16.4141%
-65.5451%
-41.372%
-30.3556%
-21.782%
34.4334%
43.2709%
44.142%
48.8683%
28.2158%
10.9226%
9.0644%
-7.878%
-13.4404%
-29.152%
-98.1836%
-159.9867%
-141.8589%
-161.9569%
-104.6954%
-34.3551%
-23.8003%
41.6775%
65.2556%
90.809%
91.8914%
86.8321%
82.6417%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.